Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Accumulated Expenses: 2010-2024

Historic Accumulated Expenses for Cryo Cell International (CCEL) over the last 15 years, with FY2024 value amounting to $5.8 million.

  • Cryo Cell International's Accumulated Expenses fell 1477.29% to $2.3 million in Q3 2025 from the same period last year, while for Aug 2025 it was $2.3 million, marking a year-over-year decrease of 1477.29%. This contributed to the annual value of $5.8 million for FY2024, which is 1235.91% up from last year.
  • Latest data reveals that Cryo Cell International reported Accumulated Expenses of $5.8 million as of FY2024, which was up 1235.91% from $5.2 million recorded in FY2023.
  • Cryo Cell International's 5-year Accumulated Expenses high stood at $5.8 million for FY2024, and its period low was $2.9 million during FY2020.
  • For the 5-year period, Cryo Cell International's Accumulated Expenses averaged around $4.1 million, with its median value being $3.6 million (2022).
  • Its Accumulated Expenses has fluctuated over the past 5 years, first surged by 549.22% in 2021, then soared by 4420.2% in 2023.
  • Annual analysis of 5 years shows Cryo Cell International's Accumulated Expenses stood at $2.9 million in 2020, then rose by 5.49% to $3.1 million in 2021, then increased by 17.28% to $3.6 million in 2022, then surged by 44.2% to $5.2 million in 2023, then grew by 12.36% to $5.8 million in 2024.
  • Its last three reported values are $5.8 million in FY2024, $5.2 million for FY2023, and $3.6 million during FY2022.